This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignees: Medice Arzneimittel Puettere Gmbh & Co. Kg, Pejo Iserlohn Heilmittel Und Diaet Gmbh & Co. Kg, Salmon Pharma Gmbh. Active years: 2013-2018.
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 1 Years Active: 2013-2018
Title: Richard Ammer: Innovator in Pharmaceutical Composition
Introduction
Richard Ammer is a notable inventor based in Iserlohn, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on developing innovative compositions that address viral infections and improve drug delivery systems.
Latest Patents
One of Richard Ammer's latest patents is an "Anti-virally effective pharmaceutical composition." This invention describes a pharmaceutical composition that includes atropine or a salt thereof, aconitine, and mercury cyanide. The composition is particularly useful in treating viral infections. Another significant patent is the "Sustained release guanfacine HCL formulation." This invention involves a pharmaceutical composition comprising guanfacine or a salt thereof in nanoparticle form, along with at least one non-pH dependent sustained release agent. The patent also details a method for producing these nanoparticles and the nanoparticles obtained through this method.
Career Highlights
Throughout his career, Richard Ammer has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Salmon Pharma GmbH and Medice Arzneimittel Pütter GmbH & Co. KG. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Richard has collaborated with several professionals in his field, including Michael Schmidbauer and Sigurd Pütter. These collaborations have likely enhanced his research and development efforts in pharmaceutical compositions.
Conclusion
Richard Ammer is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact the treatment of viral infections significantly. His innovative patents and career achievements reflect his dedication to advancing medical science.